K-FORCE - 60 CT

K-FORCE - 60 CT by Ortho Molecular Products

K-Force 60 - CT is a powerful supplement filled with Vitamin D (125 mcg per serving) and Vitamin K2 (180 mcg per serving). * Designed by Ortho Molecular Products, it may be an excellent support for your overall health and wellness, with a particular focus on your bone joint and muscle health.*

Who May Take K-Force - 60 CT?

Ortho Molecular Products recommends K-Force - 60 CT for:

• women who want to maintain a healthy bone density*
• those who want to protect and maintain their heart health*

K-Force - 60 CT—Effects?

K-Force - 60 CT may support:

• healthy calcium balance*
• optimal bone health*
• cardiovascular health and arterial elasticity*
• immunity*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Need more information about K-FORCE - 60 CT or other supplements available at Covenant Health Products? Book a FREE product consultation!

Recommendation:
Ortho Molecular Products suggest taking 1 K-FORCE capsule per day, or as directed by your healthcare professional.

Serving Size: 1 Capsule
Servings Per Container: 60

Amount Per Serving:
Vitamin D (D3 as Cholecalciferol) 125 mcg (5,000 IU)
Vitamin K2 (as Menaquinone-7 (MK7)) (MenaQ7®PUO) 180 mcg

Other Ingredients: Natural Vegetable Capsules, Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide, Stearic Acid, and Turmeric Root Extract.

Does Not Contain: Gluten, yeast, soy, artificial colors, and flavors.

Cautions: Do not consume this product if you are pregnant or nursing. All forms of vitamin K may interact with blood-thinning medications. If you are taking such medicines please consult your physician before taking this product.

MenaQ7®PRO is a registered trademark of NattoPharma,Norway.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

1. Beulens, J. W., van der A, D. L., Grobbee, D. E., Sluijs, I., Spijkerman, A. M., & van der Schouw, Y. T. (2010). Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care, 33(8), 1699-1705. https://doi.org/10.2337/dc10-0580
2. Beulens, J. W., High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis, 203(2), 489-493. https://doi.org/10.1016/j.atherosclerosis.2008.07.019
3. Choi, H. J., Yu, J., Choi, H., An, J. H., Kim, S. W., Park, K. S., Jang, H. C., Kim, S. Y., & Shin, C. S. (2011). Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: A placebo-controlled trial. Diabetes Care, 34(9), e147. https://doi.org/10.2337/dc11-0580
4. Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J., Knapen, M. H., van der Meer, I. M., Hofman, A., & Witteman, J. C. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. Journal of Nutrition, 134(11), 3100-3105. https://doi.org/10.1093/jn/134.11.3100
5. Gast, G. C., de Roos, N. M., Sluijs, I., Bots, M. L., Beulens, J. W., Geleijnse, J. M., Witteman, J. C., Grobbee, D. E., Peeters, P. H., & van der Schouw, Y. T. (2009). A high menaquinone intake reduces the incidence of coronary heart disease. Nutrition, Metabolism and Cardiovascular Diseases, 19(7), 504-510. https://doi.org/10.1016/j.numecd.2008.01.003
6. Kidd, P. M. (2010). Vitamins D and K as pleiotropic nutrients: Clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Alternative Medicine Review, 15(3), 199-222.
7. Knapen, M. H., Schurgers, L. J., & Vermeer, C. (2007). Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporosis International, 18(7), 963-972. https://doi.org/10.1007/s00198-007-0344-7
8. Knapen, M. H., Drummen, N. E., Smit, E., Vermeer, C., & Theuwissen, E. (2013). Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 24(9), 2499-2507. https://doi.org/10.1007/s00198-013-2276-1
9. Plaza, S. M., & Lamson, D. W. (2005). Vitamin K2 in bone metabolism and osteoporosis. Alternative Medicine Review, 10(1), 24-35.
10. Schurgers, L. J., Teunissen, K. J., Hamulyák, K., Knapen, M. H., Vik, H., & Vermeer, C. (2007). Vitamin K-containing dietary supplements: Comparison of synthetic vitamin K1 and natto-derived menaquinone. Blood, 109(8), 3279-3283. https://doi.org/10.1182/blood-2006-12-063222
11. Shearer, M. J. (1992). Vitamin K metabolism and nutriture. Blood Reviews, 6(2), 92-104.
12. Theuwissen, E., Smit, E., & Vermeer, C. (2012). The role of vitamin K in soft-tissue calcification. Advances in Nutrition, 3(2), 166-173. https://doi.org/10.3945/an.111.000629
13. Ushiroyama, T., Ikeda, A., & Ueki, M. (2002). Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas, 41(3), 211-221. https://doi.org/10.1016/S0378-5122(02)00002-2
14. Weber, P. (1997). Management of osteoporosis: Is there a role for vitamin K? International Journal for Vitamin and Nutrition Research, 67(5), 350-356.
15. Iijima, H., Shinzaki, S., & Takehara, T. (2012). The importance of vitamins D and K for bone health and immune function in inflammatory bowel disease. Current Opinion in Clinical Nutrition and Metabolic Care, 15(6), 635-640. https://doi.org/10.1097/MCO.0b013e328358f7b7
16. Shea, M. K., Booth, S. L., Massaro, J. M., Jacques, P. F., D’Agostino, R. B. Sr., Dawson-Hughes, B., Ordovas, J. M., O’Donnell, C. J., Kathiresan, S., Keaney, J. F. Jr., Vasan, R. S., & Benjamin, E. J. (2008). Vitamin K and vitamin D status: Associations with inflammatory markers in the Framingham Offspring Study. American Journal of Epidemiology, 167(3), 313-320. https://doi.org/10.1093/aje/kwm329
17. Geleijnse, J. M., et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. Journal of Nutrition, 134(11), 3100-3105.
18. Kaneki, M., Hodges, S. J., Hosoi, T., Fujiwara, S., Lyons, A., Crean, S. J., Ishida, N., Nakagawa, M., Takechi, M., Sano, Y., Mizuno, Y., Hoshino, S., Miyao, M., Inoue, S., Horiki, K., Shiraki, M., & Ouchi, Y. (2001). Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: Possible implications for hip-fracture risk. Nutrition, 17(4), 315-321. https://doi.org/10.1016/S0899-9007(01)00500-5
19. Van Summeren, M. J., Braam, L. A., Lilien, M. R., Schurgers, L. J., Kuis, W., & Vermeer, C. (2009). The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. British Journal of Nutrition, 102(8), 1171-1178. https://doi.org/10.1017/S0007114509990553